National Marrow Donor Program is a 501(c)(3) organization based in Minneapolis, Minnesota, registered in 1989, with $666,667,782 in FY2023 revenue. CharityIndex grades it A, and it directs about 83% of spending to programs.
Revenue (FY2023)
$666.7M
▲ 15.3% vs prior year
Health median: $840K
Expenses (FY2023)
$623.0M
Net assets
$236.3M
Employees
1,784
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For National Marrow Donor Program: 83% to programs · $4 to raise $100 earns a A on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For National Marrow Donor Program: 5 mo reserves · +7% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For National Marrow Donor Program: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For National Marrow Donor Program: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
We save lives through cellular therapy.
Research:research innovations are critical to expanding treatment to more patients and improving outcomes. each year, the nmdp foundation is proud to invest in research through:the nmdp amy strelzer manasevit research program: the amy program funds early career investigators focused on advances in the prevention and treatment of post-cell therapy complications (e.g., graft-versus-host -disease and infection).in 2024, we funded the work of 14 amy scholars. amy scholars have gone on to become leaders in the field, pursuing scientific advances that help nmdp patients live longer, healthier lives. since 1998, the nmdp foundation has invested nearly $12.5 million to help launch the careers of 51 young physician-scientists. after receiving their nmdp amy scholar award, 51 young physician-scientists have gone on to win more than $250 million in subsequent government grant funding to pursue the discoveries to help patients live longer, healthier lives after cell therapy. today, the amy strelzer manasevit research program for the study of post-cell therapy complications is one of the largest and most coveted fellowships in the field of transplantation.nmdp donor for all: this series of transformational multi-center clinical trials are testing a new transplant protocol aimed at making mismatched donor transplants safer and more effective, with the goal of expanding access to transplant to thousands of patients who lack a fully matched donor.anthony nolan trust: provide support to the anthony nolan research institute to continue development and maintenance of an hla class i and ii sequence database and provision of hla class i and ii sequence information.cibmtr (the center for international blood and marrow transplant research) a partnership between the medical college of wisconsin and nmdp is the leading hub for transplant and cell therapy research. the nmdp foundation helps to fund various other innovative research studies led and managed by the cibmtr.
Recruitment:the nmdp registry is the most diverse listing of potential donors and cord blood units in the world. every search through nmdp provides patients with access to more than 44 million potential adult donors and more than 820,000 cord blood units worldwide. the best match for a patient is typically someone who shares their ethnic background. improving the ethnic diversity of the nmdp registry improves all patients' odds of finding their best match, regardless of ethnic background.people between the ages of 18 and 30 are most urgently needed. research has shown that cells from younger donors lead to better long-term survival for patients.in fy24, more than 240,000 potential donors joined the nmdp registry and more than 4,400 umbilical cord units were added to the registry.
Public awareness: the nmdp foundation partners with nmdp to advance various initiatives. these programs include: nmdp provides comprehensive education and support services to patients and their families through one-on-one navigation support, video, printed, and digital education resources, counseling, nmdp peer connect program, nmdp survivorship program, nmdp sickle cell warrior program, and the jason carter clinical trials search and support program, which helps patients with life-threatening blood disorders find clinical trials. the nmdp foundation raises funds to support these critical services.
Revenue grew from $383.2M (FY2013) to $666.7M (FY2023) across 11 reported years.
Financial snapshot
Operating margin
6.5%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$402.7M
Total liabilities
$166.4M
Net assets
$236.3M
Salaries & benefits
$230.2M
37% of expenses
Board members
16
16 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2023 | $666,667,782▲15.3% | $623,045,301▲9.1% | $236,339,982▲19.7% | $402,742,599▲14.3% | 990 |
| 2022 | $577,983,771▲15.4% | $571,156,736▲12.2% | $197,479,218▲8.3% | $352,274,534▲13.0% | 990 |
| 2021 | $500,834,053▲12.5% | $508,871,683▲9.3% | $182,275,023▼19.1% | $311,842,955▼14.5% | 990 |
| 2020 | $445,089,731▲0.5% | $465,546,094▲4.5% | $225,288,413▼4.3% | $364,758,095▼1.9% | 990 |
| 2019 | $442,997,381▼0.5% | $445,447,669▲3.8% | $235,300,429▼6.0% | $371,669,572▼4.4% | 990 |
| 2018 | $445,357,123▲6.5% | $429,047,103▲5.6% | $250,358,231▲8.0% | $388,620,231▲6.2% | 990 |
| 2017 | $418,299,785▲7.0% | $406,237,571▲11.3% | $231,836,850▲9.1% | $365,800,299▲1.1% | 990 |
| 2016 | $391,006,899▼0.2% | $365,083,412▼1.5% | $212,425,937▲21.1% | $361,819,626▲11.3% | 990 |
| 2015 | $391,960,406▼1.4% | $370,486,191▼1.3% | $175,375,663▲18.1% | $325,206,218▲31.7% | 990 |
| 2014 | $397,637,744▲3.8% | $375,316,670▲1.9% | $148,487,521▲9.8% | $246,896,498▼7.4% | 990 |
| 2013 | $383,218,318 | $368,155,082▲1.5% | $135,220,447▲15.6% | $266,592,467▲5.2% | 990 |
| 2012 | — | $362,794,999▲9.2% | $116,935,435▲33.4% | $253,532,509▲19.3% | 990 |
| 2011 | — | $332,224,346▲9.3% | $87,673,872▲33.4% | $212,582,397▲7.8% | 990 |
| 2010 | — | $303,939,434▲7.6% | $65,745,175▲20.6% | $197,211,432▲7.0% | 990 |
| 2009 | — | $282,496,599 | $54,509,617 | $184,337,341 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Amy Ronneberg — $1,538,663 (0.25% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Amy Ronneberg | Chief Executive Officer | 48 | $1,538,663 |
| Steven Devine | Chief Medical Officer | 50 | $900,352 |
| Brian Lindberg | Chief Administrative Officer | 49 | $863,511 |
| Patricia Jones | Svp, Human Resources | 49 | $761,916 |
| Michael Mccullough | Chief Digital & Information Officer | 47 | $755,288 |
| John Miller | Vp, Medical & Quality Services | 50 | $730,844 |
| Jeffery Auletta | Chief Scientific Director | 49 | $719,360 |
| Julie Smolich | Svp, Patient & Provider Services | 49 | $690,229 |
| Krista Dusil | Chief Financial Officer (thru 2/24) | 49 | $649,755 |
| Jamie Margolis | Svp, Donor & Product Operations | 49.5 | $618,634 |
| Erica Jensen | Svp, Innovation, Strategy & Marketing | 49 | $612,013 |
| Heather Stefanski | Vp, Cibmtr & Clinical Services | 50 | $535,863 |
| Mary Hengen | Vp, Cibmtr & Clinical Services | 50 | $484,493 |
| Joy King | Chief Advancement Officer | 30 | $345,282 |
| Gina Graves | Former Officer | 0 | $239,958 |
| Anne Mcgeorge | Director | 1 | — |
| Brian Reithel | Chair | 1 | — |
| Elizabeth Shpall | Director | 1 | — |
| Garheng Kong | Director | 1 | — |
| Judith Gasson | Chair Elect | 1 | — |
| Contractor | Services | Paid |
|---|---|---|
| The Emmes Corporation | Research Data Collection | $13,655,869 |
| Coherent Solutions Inc | It Services | $6,679,092 |
| Eplus Technology | It Services | $3,841,787 |
| Hollstadt and Associates Inc | Business Consulting | $3,442,849 |
| Salesforce Inc | It Services | $3,331,417 |
36 grants to National Marrow Donor Program totaling $93.4M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Silicon Valley Community Foundation | Health | 2024 | $25,000 |
| The Medical College of Wisconsin Inc | Research subaward | 2023 | $12,524,173 |
| University of Pittsburgh | Research- subcontract | 2023 | $118,534 |
| Fred Hutchinson Cancer Center | Research support/subawards | 2023 | $87,261 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2023 | $39,125 |
| American Endowment Foundation | Health, general | 2023 | $11,500 |
| Fjc | General operating support | 2023 | $9,000 |
| Vanguard Charitable Endowment Program | For recipient's exempt purpose | 2023 | $8,000 |
| Donor Advised Charitable Giving | Health | 2023 | $5,590 |
| The Medical College of Wisconsin Inc | Research subaward | 2022 | $8,666,815 |
| University of Pittsburgh | Research- subcontract | 2022 | $123,414 |
| Fred Hutchinson Cancer Center | Translational science & therapy | 2022 | $53,987 |
| Fred Hutchinson Cancer Center | Clinical research | 2022 | $49,657 |
| Fred Hutchinson Cancer Center | Clinical research | 2022 | $49,279 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2022 | $17,250 |
4 grants totaling $7.6M in FY2023. All grants made by National Marrow Donor Program →
| Recipient | Purpose | Amount |
|---|---|---|
| Nmdp Foundation | Phrsa patient assistance funding | $7,586,216 |
| Cord Blood Association Foundation | Event sponsor | $25,000 |
| Health Occupations Students of America | Conference sponsor | $9,000 |
| Sickle Cell Consortium | Sponsorship for annual warriors convention | $8,000 |
Explore more
Data for National Marrow Donor Program (EIN 84-0865803) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.